CALGARY, Alberta, July 08, 2025 (GLOBE NEWSWIRE) -- In a significant move that bridges biotechnology, preventive health, and global wellness…
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 1.925 MILLION PRIVATE PLACEMENT Paris, July 8, 2025, 8am…
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, July 08, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a…
PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and…
Exclusive agreement includes over $70 million in upfront and milestone payments to LENZ in addition to double-digit royalties on net…
July 07, 2025 08:00 ET | Source: KALA BIO, Inc. ARLINGTON, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- KALA BIO,…
PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3 TRIAL IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER, WITH BIOMARKER-DRIVEN…
July 04, 2025 02:00 ET | Source: Orion Oyj ORION CORPORATION PRESS RELEASE 4 JULY 2025 at 09.00 EEST …
The expert jury selected Dragan Grabulovski, Ph.D., Philipp Spycher, Ph.D., and Isabella Attinger-Toller, Ph.D. of Araris Biotech, from a group…
Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions Distinguished experts Dr. Jay Skyler, Dr. Desmond Schatz,…